<code id='BEE047F088'></code><style id='BEE047F088'></style>
    • <acronym id='BEE047F088'></acronym>
      <center id='BEE047F088'><center id='BEE047F088'><tfoot id='BEE047F088'></tfoot></center><abbr id='BEE047F088'><dir id='BEE047F088'><tfoot id='BEE047F088'></tfoot><noframes id='BEE047F088'>

    • <optgroup id='BEE047F088'><strike id='BEE047F088'><sup id='BEE047F088'></sup></strike><code id='BEE047F088'></code></optgroup>
        1. <b id='BEE047F088'><label id='BEE047F088'><select id='BEE047F088'><dt id='BEE047F088'><span id='BEE047F088'></span></dt></select></label></b><u id='BEE047F088'></u>
          <i id='BEE047F088'><strike id='BEE047F088'><tt id='BEE047F088'><pre id='BEE047F088'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:9932
          Surgeons look over an x-ray monitor showing an implanted pacemaker — coverage from STAT
          Adobe

          In her final presentation for health policy class at the University of Chicago, first-year medical student Robin Ji informed her classmates that the Food and Drug Administration does not require randomized controlled trials of most medical devices. Her peers’ immediate reaction was disbelief.

          “One classmate kept asking me, are you sure?” Ji said. “I think he asked me twice. Then he went on his phone to check to see if it was actually true.”

          advertisement

          Ji was sure. She had spent two years before going to medical school working as a policy analyst for Rita Redberg and Sanket Dhruva, medical safety experts at the University of California, San Francisco. In a recent national survey published by the UCSF team in Health Affairs, Ji learned that it’s not just her classmates who may have misconceptions about the FDA — only 17% of physicians surveyed felt they understood the FDA’s device approval process. Around 41% felt they understood the drug side.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          FTC falls short on scrutinizing hospital mergers, study says
          FTC falls short on scrutinizing hospital mergers, study says

          AdobeOverthepasttwodecades,hundredsofhospitalmergershaveescapedfederalantitrustscrutinyandledtobothh

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Bird flu in milk supply is likely coming from asymptomatic cows

          AdobeSinceMarch,whenthefirstreportedcasesofH5N1birdflubeganshowingupindairycattleinTexas,theFoodandD